Factors Associated With Medication Use Among Individuals Living With Multiple Sclerosis.

IF 3.3 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE

Journal of Evidence-based Integrative Medicine Pub Date : 2020-01-01 DOI:10.1177/2515690X20936978

Khrisha B Alphonsus, Carl D'Arcy

{"title":"Factors Associated With Medication Use Among Individuals Living With Multiple Sclerosis.","authors":"Khrisha B Alphonsus, Carl D'Arcy","doi":"10.1177/2515690X20936978","DOIUrl":null,"url":null,"abstract":"<p><p>Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system causing neurological deterioration over time. The objective of this study was to examine the predictors associated with MS medication use. The categories that were investigated were various alternative treatments such as complementary/alternative medications (CAMs), rehabilitation therapy and psychotherapy services as well as comorbid health conditions. The Survey on Living with Neurological Conditions in Canada (SLNCC) 2011-2012 was used (N = 73 347) to carry out a logistic regression model. Individuals who did not take CAMs were more (OR = 5.44, 95% CI 1.37-9.29) likely to use medications for MS. Having a mood disorder was associated with greater use of MS medications (OR = 5.39, 95% CI 1.60-18.17) while back problems were associated with lower odds of medication use (OR = 0.38, 95% CI 0.15-0.98). These factors need to be taken into consideration when creating effective medication adherence interventions.</p>","PeriodicalId":15714,"journal":{"name":"Journal of Evidence-based Integrative Medicine","volume":"25 ","pages":"2515690X20936978"},"PeriodicalIF":3.3000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/2515690X20936978","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Evidence-based Integrative Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/2515690X20936978","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}

引用次数: 0

Abstract

Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system causing neurological deterioration over time. The objective of this study was to examine the predictors associated with MS medication use. The categories that were investigated were various alternative treatments such as complementary/alternative medications (CAMs), rehabilitation therapy and psychotherapy services as well as comorbid health conditions. The Survey on Living with Neurological Conditions in Canada (SLNCC) 2011-2012 was used (N = 73 347) to carry out a logistic regression model. Individuals who did not take CAMs were more (OR = 5.44, 95% CI 1.37-9.29) likely to use medications for MS. Having a mood disorder was associated with greater use of MS medications (OR = 5.39, 95% CI 1.60-18.17) while back problems were associated with lower odds of medication use (OR = 0.38, 95% CI 0.15-0.98). These factors need to be taken into consideration when creating effective medication adherence interventions.

Abstract Image

查看原文本刊更多论文

多发性硬化症患者用药的相关因素

多发性硬化症(MS)是一种慢性自身免疫性疾病，影响中枢神经系统，导致神经系统随着时间的推移而恶化。本研究的目的是检查与MS药物使用相关的预测因素。调查的类别是各种替代治疗，如补充/替代药物(CAMs)、康复治疗和心理治疗服务以及共病健康状况。采用2011-2012年加拿大神经系统疾病患者生活状况调查(SLNCC) (N = 73 347)进行logistic回归模型。没有服用CAMs的个体更有可能使用多发性硬化症药物(OR = 5.44, 95% CI 1.37-9.29)。有情绪障碍的个体更有可能使用多发性硬化症药物(OR = 5.39, 95% CI 1.60-18.17)，而背部问题的个体使用药物的几率更低(OR = 0.38, 95% CI 0.15-0.98)。在制定有效的药物依从性干预措施时，需要考虑这些因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊